I'm Not Waiting for Something to Go Wrong
Most people I speak to in Ireland take the same approach to their health: wait until there's a problem, then deal with it. I understand that instinct — we're all busy, the health system is stretched, and if nothing's broken, why fix it? But when I started looking seriously at cardiovascular health in the context of higher-volume training cycles, I realised that waiting for a problem to appear is exactly the wrong strategy. By the time your blood pressure is consistently elevated, or your lipid panel looks rough, you've already let things run in the wrong direction for longer than you should have. This post is about how I think about cardiovascular protection — specifically around blood pressure management — and why I've built a proactive, data-driven protocol rather than a reactive one.
Why I Started Researching This
My natural blood pressure sits at around 110/78. That's genuinely good — I'm not someone who came to this because I had a problem. I came to it because I understood that certain training phases and the compounds associated with them have well-documented effects on blood pressure, haematocrit, and lipid profiles. If you're running higher training volumes or introducing anything that increases red blood cell production or water retention, your cardiovascular system is under additional load. That's not a scare story — it's just physiology. What I wanted was a framework for staying on top of those variables before they became something I'd need to manage reactively. The Irish medical system, like most, is not set up to help you optimise — it's set up to treat illness. If you want to be proactive, you have to build that structure yourself.
What the Research Actually Says
Telmisartan is an angiotensin II receptor blocker — an ARB — and it's been studied extensively for its blood pressure lowering effects, but there's a layer of research that goes beyond simple BP management that I found genuinely interesting. Studies indicate that Telmisartan has a relatively long half-life compared to other ARBs, which means once-daily dosing maintains more consistent coverage over a 24-hour period. Research also suggests it has some affinity for the PPAR-gamma receptor, which is associated with metabolic regulation and has led to investigations into its effects on insulin sensitivity and lipid metabolism — though those findings are still being explored and I want to be clear that this is an active area of research rather than settled science.
From a cardiovascular protection standpoint, the mechanism that matters most practically is its role in reducing systemic vascular resistance. When training volume is high and compounds are involved that can increase haematocrit — thickening the blood effectively — your heart is working harder to push that blood around. Research suggests that ARBs like Telmisartan can help offset some of that increased load on the heart and arterial walls. At the doses typically used — 20mg to 80mg daily — it's considered well-tolerated, though as with any pharmaceutical, individual response varies and working with a GP is the appropriate path if you're considering it for clinical use. My interest here is purely from a research and personal monitoring perspective.
My Personal Experience
Here's the thing I keep coming back to: Telmisartan goes in before the cycle ramps up, not after. That's the whole point. If I waited until my blood pressure was creeping past 120/80 and then introduced a BP-lowering agent, I'd be managing a problem. Instead, I start at 20mg daily when I'm planning a higher-volume phase, and I have a clear titration plan — if readings start trending upward past 120/80 during monitoring, I move to 40mg, and if needed, 80mg. So far I haven't needed to go beyond 20mg to maintain the numbers I'm happy with.
The monitoring side of this is non-negotiable for me. I track HDL, LDL, triglycerides, and haematocrit at regular intervals — not just at the start and end of a cycle, but throughout. I remember a point about four months into a longer training phase when my haematocrit had moved more than I'd expected. Nothing alarming in isolation, but it was exactly the kind of thing that matters in the context of cardiovascular load. Because I was already on 20mg Telmisartan and monitoring consistently, I had data to work with rather than a surprise at a GP visit six months later. That's the difference between a proactive and a reactive approach in practice — not just in theory.
I also use a decent home blood pressure monitor. Sounds basic, but taking your own readings at the same time of day, in the same conditions, over weeks and months gives you a far more accurate picture than a single reading in a medical setting. In Ireland, white coat hypertension is real — stress of the environment pushes numbers up temporarily. Home monitoring removes that variable.
What I'd Tell Someone Considering This
First — bloodwork before anything else. You need a baseline lipid panel and haematocrit before you can make any meaningful decisions. If you're in Ireland, you can get a private blood test without a GP referral through several services, and it's worth doing. Without baseline data, you're flying blind.
Second, if Telmisartan is something you're researching for personal use — and this is purely a research framing, I'm not offering medical advice — start at the lower end. 20mg is a reasonable starting point. Many people find that sufficient. Don't jump to higher doses without reason and without monitoring to justify the adjustment.
Third, track everything and track it consistently. The value isn't in any single data point — it's in the trend over time. BP readings, blood markers, how you feel under load during training. Keep a log. This is worth more than any supplement or compound you'll ever buy.
Fourth, don't treat cardiovascular markers as a one-dimensional thing. LDL on its own tells you less than LDL in relation to HDL and triglycerides together. Haematocrit matters in combination with blood pressure and hydration status. Build a picture, not a single number.
Summary
The core principle behind my cardiovascular approach is straightforward: don't wait for a problem before you start paying attention. My natural BP of 110/78 is a good starting point, but I know what higher-volume training phases can do to cardiovascular load — so Telmisartan at 20mg, titrated as needed, goes in proactively. Combined with regular monitoring of HDL, LDL, triglycerides, and haematocrit, I have a data set I can actually work with rather than a vague sense that things are probably fine. In my experience, that kind of structured, numbers-driven approach is what separates people who stay healthy long-term from people who manage crises.
If you're at the early stages of building your own health and performance monitoring framework, the free tools at irishpeptides.ie/free-tools are a useful starting point — there's a macro calculator, cycle length planner, and dosing frequency tool there that I built specifically for people who want to take a more data-driven approach to their nutrition and wellness protocols.